3 Areas of Opportunity for Private Equity Investment in Life Sciences


The life sciences investment space has been largely immune to the negative impacts of the COVID-19 pandemic. Growth in the pharmaceutical, biotechnology and medical device industries has led to increased interest from private equity investors, many of which are new to the life sciences market.

In this video we address:

  • Three areas ripe for private equity investment in the life sciences arena
  • Sector-specific due diligence concerns investors should address
  • Opportunities for ROI when investing in life sciences and life sciences adjacent companies

Dig Deeper

Webinar / HCCA / November 8-10, 2021

HCCA's Healthcare Enforcement Compliance Conference

Virtual Conference / Speaking Engagements / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity

Webinar / Speaking Engagements / October 18, 2021

HLTH Boston 2021

Virtual Event / McDermott Event / October 15, 2021

HPE New York 2021

Webinar / Dynamic Global Events / October 11-12, 2021

2nd REMS Virtual Summit

Get In Touch